Compounds > safinamide

Page last updated: 2024-09-03

safinamide and Aura

safinamide has been researched along with Aura in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	4 (80.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fariello, RG	1
Chazot, PL	2
Fariello, RG; Maj, R; McArthur, RA; Pevarello, P; Salvati, P; Ukmar, G; Varasi, M	1

Reviews

4 review(s) available for safinamide and Aura

Article	Year
Safinamide: FCE 26743, NW 1015, PNU 151774, PNU 151774E. Drugs in R&D, 2004, Volume: 5, Issue:6 Topics: Alanine; Animals; Anticonvulsants; Antiparkinson Agents; Benzylamines; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Epilepsy; Humans; Parkinson Disease	2004
Safinamide. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2007, Volume: 4, Issue:1 Topics: Alanine; Animals; Anticonvulsants; Benzylamines; Brain; Clinical Trials as Topic; Epilepsy; Humans; Parkinson Disease	2007
Safinamide for the treatment of Parkinson's disease, epilepsy and restless legs syndrome. Current opinion in investigational drugs (London, England : 2000), 2007, Volume: 8, Issue:7 Topics: Alanine; Animals; Benzylamines; Clinical Trials as Topic; Epilepsy; Humans; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Restless Legs Syndrome	2007
Safinamide (Newron Pharmaceuticals). Current opinion in investigational drugs (London, England : 2000), 2001, Volume: 2, Issue:6 Topics: Alanine; Animals; Anticonvulsants; Antiparkinson Agents; Benzylamines; Clinical Trials as Topic; Contraindications; Epilepsy; Humans; Parkinson Disease; Structure-Activity Relationship	2001

Other Studies

1 other study(ies) available for safinamide and Aura

Article	Year
PNU-151774E protects against kainate-induced status epilepticus and hippocampal lesions in the rat. European journal of pharmacology, 1998, Oct-16, Volume: 359, Issue:1 Topics: Alanine; Animals; Anticonvulsants; Benzylamines; Diazepam; Epilepsy; Hippocampus; Kainic Acid; Lamotrigine; Male; Neuroprotective Agents; Rats; Rats, Wistar; Triazines	1998